Home > Healthcare > Biotechnology > Biotechnology R&D > Human Microbiome Market
Increasing funding initiatives and government programs have emerged as potent drivers propelling the development of the industry. Recognizing the pivotal role that the human microbiome plays in maintaining overall health and its potential in revolutionizing disease management, governments and institutions worldwide are redirecting substantial investments toward research and development in this field. For instance, as per the National Institute of Health, in May 2022, the Federal Government of the U.S. incurred USD 864 million on research and development of the microbiome in 2021 and is expected to spend USD 903 million in 2022. Moreover, the establishment of supportive regulatory frameworks and incentives further augments this momentum, attracting both established players and new entrants to invest in microbiome-focused ventures.